New report lays out roadmap to biomanufacturing ‘moment’—predicts explosion to $200 billion market over next decade

In a newly released report published in collaboration with Synonym, Boston Consulting Group names next-generation biofoundries as key catalyst for the coming wave of superior, sustainable products.

• Production capacity and cost are main hurdles to unlocking a large-scale biomanufacturing boom, with $200 billion speciality market a conservative estimate if expansion model achieved
• Creation of multi-function fermentation facilities represent an ‘enormous opportunity for infrastructure investment’ that will de-risk sector and enable industrial-scale production of superior food, materials, chemicals and more—but only with immediate investment
• A single biofoundry would have more capacity than available currently globally at some 2 million liters each; visionary roadmap suggests 1,000 such facilities worldwide with a combined capacity of 2.4 billion liters

NEW YORK, 27 February, 2024 — Synonym, a biomanufacturing infrastructure company, is unlocking the market forces to enable a quickly-maturing multi-hundred billion dollar sector—which will “allow biomanufacturing [to] finally fulfill its promise of achieving commercial scale.”

So says a new report by leading global consulting firm Boston Consulting Group (BCG) (coauthored by Synonym), entitled